{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:26:02Z","timestamp":1777055162826,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"MSD","award":["Unrestricted educational grant"],"award-info":[{"award-number":["Unrestricted educational grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2019,3,14]]},"DOI":"10.1007\/s40520-019-01154-1","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T15:22:25Z","timestamp":1551108145000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adult vaccination as the cornerstone of successful ageing: the case of herpes zoster vaccination. A European Interdisciplinary Council on Ageing (EICA) expert focus group"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4224-9731","authenticated-orcid":false,"given":"Fiona","family":"Ecarnot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bernabei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Gabutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Rezza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"key":"1154_CR1","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1073\/pnas.1704507114","volume":"114","author":"WA Orenstein","year":"2017","unstructured":"Orenstein WA, Ahmed R (2017) Simply put: vaccination saves lives. Proc Natl Acad Sci USA 114:4031\u20134033. https:\/\/doi.org\/10.1073\/pnas.1704507114","journal-title":"Proc Natl Acad Sci USA"},{"key":"1154_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/cid\/cix468","volume":"65","author":"C Arriola","year":"2017","unstructured":"Arriola C, Garg S, Anderson EJ, Ryan PA, George A, Zansky SM, Bennett N, Reingold A, Bargsten M, Miller L, Yousey-Hindes K, Tatham L, Bohm SR, Lynfield R, Thomas A, Lindegren ML, Schaffner W, Fry AM, Chaves SS (2017) Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza. Clin Infect Dis 65:1289\u20131297. https:\/\/doi.org\/10.1093\/cid\/cix468","journal-title":"Clin Infect Dis"},{"key":"1154_CR3","doi-asserted-by":"publisher","first-page":"e1176","DOI":"10.1016\/S2214-109X(17)30364-9","volume":"5","author":"AS Ginsburg","year":"2017","unstructured":"Ginsburg AS, Klugman KP (2017) Vaccination to reduce antimicrobial resistance. Lancet Glob Health 5:e1176\u2013e1177. https:\/\/doi.org\/10.1016\/S2214-109X(17)30364-9","journal-title":"Lancet Glob Health"},{"key":"1154_CR4","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1016\/j.vaccine.2017.09.006","volume":"35","author":"MF Howitz","year":"2017","unstructured":"Howitz MF, Harboe ZB, Ingels H, Valentiner-Branth P, Molbak K, Djurhuus BD (2017) A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000\u20132014. Vaccine 35:5858\u20135863. https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.006","journal-title":"Vaccine"},{"key":"1154_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40520-018-0956-3","volume":"30","author":"E Zorzoli","year":"2018","unstructured":"Zorzoli E, Pica F, Masetti G, Franco E, Volpi A, Gabutti G (2018) Herpes zoster in frail elderly patients: prevalence, impact, management, and preventive strategies. Aging Clin Exp Res 30:693\u2013702. https:\/\/doi.org\/10.1007\/s40520-018-0956-3","journal-title":"Aging Clin Exp Res"},{"issue":"Suppl 2","key":"1154_CR6","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1086\/522152","volume":"197","author":"K Schmader","year":"2008","unstructured":"Schmader K, Gnann JW Jr, Watson CP (2008) The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 197(Suppl 2):S207\u2013S215. https:\/\/doi.org\/10.1086\/522152","journal-title":"J Infect Dis"},{"key":"1154_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0735-1","author":"ET Chiyaka","year":"2018","unstructured":"Chiyaka ET, Nghiem VT, Zhang L, Deshpande A, Mullen PD, Le P (2018) Cost-effectiveness of herpes zoster vaccination: a systematic review. Pharmacoeconomics. https:\/\/doi.org\/10.1007\/s40273-018-0735-1","journal-title":"Pharmacoeconomics"},{"key":"1154_CR8","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/infdis\/jiw462","volume":"214","author":"A Lelic","year":"2016","unstructured":"Lelic A, Verschoor CP, Lau VW, Parsons R, Evelegh C, Bowdish DM, Bramson JL, Loeb MB (2016) Immunogenicity of varicella vaccine and immunologic predictors of response in a cohort of elderly nursing home residents. J Infect Dis 214:1905\u20131910. https:\/\/doi.org\/10.1093\/infdis\/jiw462","journal-title":"J Infect Dis"},{"key":"1154_CR9","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL, Shingles Prevention Study G (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271\u20132284. https:\/\/doi.org\/10.1056\/NEJMoa051016","journal-title":"N Engl J Med"},{"key":"1154_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.08.037","author":"I Matthews","year":"2018","unstructured":"Matthews I, Lu X, Dawson H, Bricout H, O\u2019Hanlon H, Yu E, Nozad B (2018) Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom. Vaccine. https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.037","journal-title":"Vaccine"},{"key":"1154_CR11","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S2468-2667(17)30234-7","volume":"3","author":"G Amirthalingam","year":"2018","unstructured":"Amirthalingam G, Andrews N, Keel P, Mullett D, Correa A, de Lusignan S, Ramsay M (2018) Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study. Lancet Public Health 3:e82\u2013e90. https:\/\/doi.org\/10.1016\/S2468-2667(17)30234-7","journal-title":"Lancet Public Health"},{"key":"1154_CR12","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barbera J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC, Group ZOES (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372:2087\u20132096. https:\/\/doi.org\/10.1056\/NEJMoa1501184","journal-title":"N Engl J Med"},{"key":"1154_CR13","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barbera J, Vanden Abeele C, Vesikari T, Watanabe D, Zahaf T, Ahonen A, Athan E, Barba-Gomez JF, Campora L, de Looze F, Downey HJ, Ghesquiere W, Gorfinkel I, Korhonen T, Leung E, McNeil SA, Oostvogels L, Rombo L, Smetana J, Weckx L, Yeo W, Heineman TC, Group ZOES (2016) Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 375:1019\u20131032. https:\/\/doi.org\/10.1056\/NEJMoa1603800","journal-title":"N Engl J Med"},{"key":"1154_CR14","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1080\/21645515.2018.1442162","volume":"14","author":"TF Schwarz","year":"2018","unstructured":"Schwarz TF, Volpe S, Catteau G, Chlibek R, David MP, Richardus JH, Lal H, Oostvogels L, Pauksens K, Ravault S, Rombo L, Sonder G, Smetana J, Heineman T, Bastidas A (2018) Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults. Hum Vaccin Immunother 14:1370\u20131377. https:\/\/doi.org\/10.1080\/21645515.2018.1442162","journal-title":"Hum Vaccin Immunother"},{"key":"1154_CR15","unstructured":"Notiziario Chimico Farmaceutico (2017) \u201cNeuropathic pain from herpes zoster: patients\u2019 experience\u201d survey. https:\/\/www.notiziariochimicofarmaceutico.it\/2017\/10\/23\/indagine-il-dolore-neuropatico-da-fuoco-di-santantonio\/. Accessed 14 Dec 2018"},{"key":"1154_CR16","doi-asserted-by":"publisher","first-page":"e011539","DOI":"10.1136\/bmjopen-2016-011539","volume":"6","author":"N Valente","year":"2016","unstructured":"Valente N, Lupi S, Stefanati A, Cova M, Sulcaj N, Piccinni L, Group GPS, Gabutti G (2016) Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study. BMJ Open 6:e011539. https:\/\/doi.org\/10.1136\/bmjopen-2016-011539","journal-title":"BMJ Open"},{"key":"1154_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ypmed.2010.12.010","volume":"52","author":"AF Dempsey","year":"2011","unstructured":"Dempsey AF, Schaffer SE (2011) Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines. Prev Med 52:268\u2013269. https:\/\/doi.org\/10.1016\/j.ypmed.2010.12.010","journal-title":"Prev Med"},{"key":"1154_CR18","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1016\/j.vaccine.2018.06.020","volume":"36","author":"AK Shen","year":"2018","unstructured":"Shen AK, Warnock R, Chu S, Kelman JA (2018) Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013\u20132015. Vaccine 36:4399\u20134403. https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.020","journal-title":"Vaccine"},{"key":"1154_CR19","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/j.1532-5415.2007.01397.x","volume":"55","author":"B Kerzner","year":"2007","unstructured":"Kerzner B, Murray AV, Cheng E, Ifle R, Harvey PR, Tomlinson M, Barben JL, Rarrick K, Stek JE, Chung MO, Schodel FP, Wang WW, Xu J, Chan IS, Silber JL, Schlienger K (2007) Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older. J Am Geriatr Soc 55:1499\u20131507. https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01397.x","journal-title":"J Am Geriatr Soc"},{"key":"1154_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.vaccine.2017.08.029","volume":"36","author":"MJ Levin","year":"2018","unstructured":"Levin MJ, Buchwald UK, Gardner J, Martin J, Stek JE, Brown E, Popmihajlov Z (2018) Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine. Vaccine 36:179\u2013185. https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.029","journal-title":"Vaccine"},{"key":"1154_CR21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.4161\/hv.6.11.12852","volume":"6","author":"CR MacIntyre","year":"2010","unstructured":"MacIntyre CR, Egerton T, McCaughey M, Parrino J, Campbell BV, Su SC, Pagnoni MF, Stek JE, Xu J, Annunziato PW, Chan IS, Silber JL (2010) Concomitant administration of zoster and pneumococcal vaccines in adults \u2265\u200960 years old. Hum Vaccin 6:894\u2013902","journal-title":"Hum Vaccin"},{"key":"1154_CR22","first-page":"1","volume":"57","author":"R Harpaz","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices Centers for Disease C, Prevention (2008) Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57:1\u201330; quiz CE32-34","journal-title":"MMWR Recomm Rep"},{"key":"1154_CR23","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1016\/j.vaccine.2011.03.018","volume":"29","author":"HF Tseng","year":"2011","unstructured":"Tseng HF, Smith N, Sy LS, Jacobsen SJ (2011) Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine. Vaccine 29:3628\u20133632. https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.018","journal-title":"Vaccine"},{"key":"1154_CR24","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/aje\/kwy076","volume":"187","author":"K Bruxvoort","year":"2018","unstructured":"Bruxvoort K, Sy LS, Luo Y, Tseng HF (2018) Real-world evidence for regulatory decisions: concomitant administration of zoster vaccine live and pneumococcal polysaccharide vaccine. Am J Epidemiol 187:1856\u20131862. https:\/\/doi.org\/10.1093\/aje\/kwy076","journal-title":"Am J Epidemiol"},{"key":"1154_CR25","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1093\/infdis\/jiy421","volume":"218","author":"PB Gilbert","year":"2018","unstructured":"Gilbert PB, Luedtke AR (2018) Statistical learning methods to determine immune correlates of herpes zoster in vaccine efficacy trials. J Infect Dis 218:S99\u2013S101. https:\/\/doi.org\/10.1093\/infdis\/jiy421","journal-title":"J Infect Dis"},{"key":"1154_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-019-01145-2","author":"S Giuffrida","year":"2019","unstructured":"Giuffrida S (2019) Calabria: a successful experience implementing Herpes Zoster vaccination strategies. Aging Clin Exp Res. https:\/\/doi.org\/10.1007\/s40520-019-01145-2","journal-title":"Aging Clin Exp Res"},{"key":"1154_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40520-015-0315-6","volume":"27","author":"JP Michel","year":"2015","unstructured":"Michel JP (2015) Herpes zoster vaccine: a shot to maintain wellbeing. Aging Clin Exp Res 27:1\u20133. https:\/\/doi.org\/10.1007\/s40520-015-0315-6","journal-title":"Aging Clin Exp Res"},{"key":"1154_CR28","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/cid\/ciu098","volume":"58","author":"SM Langan","year":"2014","unstructured":"Langan SM, Minassian C, Smeeth L, Thomas SL (2014) Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis 58:1497\u20131503. https:\/\/doi.org\/10.1093\/cid\/ciu098","journal-title":"Clin Infect Dis"},{"key":"1154_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/WNL.0000000000000038","volume":"82","author":"J Breuer","year":"2014","unstructured":"Breuer J, Pacou M, Gauthier A, Brown MM (2014) Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology 82:206\u2013212. https:\/\/doi.org\/10.1212\/WNL.0000000000000038","journal-title":"Neurology"},{"key":"1154_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s13365-013-0183-9","volume":"20","author":"MA Nagel","year":"2014","unstructured":"Nagel MA (2014) Varicella zoster virus vasculopathy: clinical features and pathogenesis. J Neurovirol 20:157\u2013163. https:\/\/doi.org\/10.1007\/s13365-013-0183-9","journal-title":"J Neurovirol"},{"key":"1154_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11908-014-0407-z","volume":"16","author":"MA Nagel","year":"2014","unstructured":"Nagel MA, Gilden D (2014) Update on varicella zoster virus vasculopathy. Curr Infect Dis Rep 16:407. https:\/\/doi.org\/10.1007\/s11908-014-0407-z","journal-title":"Curr Infect Dis Rep"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-019-01154-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01154-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01154-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T17:15:47Z","timestamp":1659114947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-019-01154-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,14]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1007\/s40520-019-01154-1","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]},"assertion":[{"value":"2 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Fiona Ecarnot, Sandro Giuffrida, Jean-Pierre Michel and Giovanni Rezza have no conflicts of interest to declare. The meeting was organized with the help of an unrestricted educational grant from MSD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}